• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/19/2018
Event Type  malfunction  
Manufacturer Narrative
Unique identifier (udi)#: (b)(4).
 
Event Description
The patient stated that he received erroneous results when testing with coaguchek xs meter serial number (b)(4).At 11:53 a.M., a sample from the patient resulted as 3.6 inr.At 11:57 a.M., the patient collected a sample from the same fingerstick by squeezing and this resulted as 2.7 inr.The patient reported the 2.7 inr value.No adverse events were alleged to have occurred with the patient.The patient did not receive treatment based on the meter results.The patient's therapeutic range is 2 - 3 inr.The patient's testing frequency is once every two weeks.The patient is not anemic or polycythemic.The patient does not have antiphospholipid antibodies.The patient does not take heparin, lovenox, or thrombin inhibitors.The patient did not have any changes in diet, medications, or illnesses.The patient had no bruising or bleeding.The patient injured his rib cage recently and only took tylenol for this.The meter had not been cleaned under the blue lid.The patient's product has been requested for investigation and replacement product was sent to the patient.Relevant retention test strips (lot 235609-23) were tested in comparison with the current master lot coaguchek xs pt test strip.For this purpose two human blood samples from marcumar donors and two internal reference meters were used.No error messages occurred.Retention samples were within specifications.
 
Manufacturer Narrative
The patient's meter was received for investigation.The returned meter was tested in comparison to a retention meter and master lot strips.Human blood samples from warfarin donors were used.Donor 1 inr: 2.4 inr, donor 2 inr: 2.8 inr.Donor 1 hct: 47%, donor 2 hct: 38%.Testing results: donor 1: retention meter with master lot strips: 2.4 inr, customer meter with master lot strips: 2.4 inr.Donor 2: retention meter with master lot strips: 2.8 inr, customer meter with master lot strips: 2.8 inr.All inr values were within the specified maximum difference between measurements.No error messages occurred.The returned and the retention material meet the specifications.As the customer used the same fingerstick for multiple tests, this is a potential cause for the result discrepancy.Product labeling advises to use a different finger for each test performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7392337
MDR Text Key104415961
Report Number1823260-2018-01029
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 05/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/03/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/30/2018
Device Catalogue Number04625374160
Device Lot Number23560923
Was Device Available for Evaluation? No
Date Manufacturer Received03/19/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
B3; FOLIC ACID; LIPITOR; LOSARTAN; MAGNESIUM; METFORMIN; PROZAC; TRICOR; VITAMINS-B COMPLEX; WARFARIN
Patient Age74 YR
Patient Weight87
-
-